
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Managing inflammatory bowel disease: what to do when the best is unaffordable?
Rupa Banerjee, Nalini Raghunathan, Partha Pal
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 5, pp. 396-398
Closed Access | Times Cited: 4
Rupa Banerjee, Nalini Raghunathan, Partha Pal
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 5, pp. 396-398
Closed Access | Times Cited: 4
Showing 4 citing articles:
The Cost of Inflammatory Bowel Disease Care – How to Make it Sustainable
Johan Burisch, Jennifer Claytor, Inmaculada Hernandez, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 23, Iss. 3, pp. 386-395
Open Access | Times Cited: 6
Johan Burisch, Jennifer Claytor, Inmaculada Hernandez, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 23, Iss. 3, pp. 386-395
Open Access | Times Cited: 6
Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care
Ahmed B. Bayoumy, Chris J. Mulder, Azhar Ansari, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 36-47
Open Access | Times Cited: 5
Ahmed B. Bayoumy, Chris J. Mulder, Azhar Ansari, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 36-47
Open Access | Times Cited: 5
Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease
Le Liu, Liping Liang, Chenghai Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Le Liu, Liping Liang, Chenghai Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis
Kristine Paridaens, M Freddi, Simon Travis
Frontiers in Gastroenterology (2024) Vol. 3
Open Access
Kristine Paridaens, M Freddi, Simon Travis
Frontiers in Gastroenterology (2024) Vol. 3
Open Access